Won B. Kim

500 citations

32 papers · 461 indexed · h-index 13

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 22
- Antibiotics Pharmacokinetics and Efficacy 11
- Drug-Induced Hepatotoxicity and Protection 3
Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 22
- Antibiotics Pharmacokinetics and Efficacy 11
- Drug-Induced Hepatotoxicity and Protection 3
Oncology
- Drug Transport and Resistance Mechanisms 11
Endocrinology, Diabetes and Metabolism
- Hormonal and reproductive studies 10
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 8
Psychiatry and Mental health
- Sexual function and dysfunction studies 6
Molecular Biology
- Cancer therapeutics and mechanisms 3

Co-authors: Jong Won Kwon Myung G. Lee Hyun Joo Shim So H. Kim Soo Kyung Bae Eun Jig Lee Myung Gyoon Lee Moohi Yoo
Cited by: Pharmacology Oncology Endocrinology, Diabetes and Metabolism
Journals: Biopharmaceutics & Drug Disposition (19 papers)Journal of Pharmaceutical Sciences (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)
Partner nations: South Korea

In The Last Decade

Won B. Kim

31 papers receiving 450 citations

Peers

Countries citing papers authored by Won B. Kim

Since Specialization

Citations

This map shows the geographic impact of Won B. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won B. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won B. Kim more than expected).

Fields of papers citing papers by Won B. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won B. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won B. Kim. The network helps show where Won B. Kim may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Won B. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Won B. Kim Line = papers co-authored together Won B. Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dose‐independent pharmacokinetics of torasemide after intravenous and oral administration to rats Biopharmaceutics & Drug Disposition ·M. Muraoka,Z. Jin,Sibo Zhao,Jong Won Kwon,Won B. Kim,Myung G. Lee	2005	13
2	Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats Biopharmaceutics & Drug Disposition ·John J. Shaughnessy,Hyun Joo Shim,K Shao,恭子小野,Jong Won Kwon,Won B. Kim,Myung G. Lee	2005	21
3	Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA‐8159, a new erectogenic, in rats Biopharmaceutics & Drug Disposition ·Joo H. Lee,Soo Kyung Bae,Jong Won Kwon,Won B. Kim,Myung G. Lee	2005	1
4	Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans Biopharmaceutics & Drug Disposition ·Hyun Joo Shim,Sibo Zhao,Joo H. Lee,Shuning Li,Jong Won Kwon,Won B. Kim,Myung G. Lee	2005	8
5	Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics Biopharmaceutics & Drug Disposition ·Hyun Joo Shim,John J. Shaughnessy,K Shao,Jong Won Kwon,Won B. Kim,Christopher Lawrence Keithley,So H. Kim,Gerald Hammer	2005	14
6	Effects of acute renal failure on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats Biopharmaceutics & Drug Disposition ·Soo Kyung Bae,Jong Won Kwon,Won B. Kim,Inchul Lee,Myung G. Lee	2005	2
7	Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate Biopharmaceutics & Drug Disposition ·Hyun Joo Shim,Sibo Zhao,Mr.Yash Kawadkar,Carlos Iván Obando Revelo,Jong Won Kwon,Won B. Kim,Myung G. Lee	2004	3
8	Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate Biopharmaceutics & Drug Disposition ·Sunesha Mohan,Joo H. Lee,Jong Won Kwon,Won B. Kim,Sang G. Kim,Evangelos D. Lolis,Myung G. Lee	2004	24
9	Pharmacokinetics, blood partition and protein binding of DA‐7867, a new oxazolidinone Biopharmaceutics & Drug Disposition ·Soo Kyung Bae,Woo Kyung Chung,Mr.Yash Kawadkar,翟朝晖,Jong Won Kwon,Won B. Kim,叶飞华	2004	14
10	Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin Journal of Pharmaceutical Sciences ·Sibo Zhao,Jong Won Kwon,Won B. Kim,Inchul Lee,Myung G. Lee	2004	9
11	Excretion and Metabolism of DA-7867, a New Oxazolidinone, in Rats Biopharmaceutics & Drug Disposition ·Soo Kyung Bae,Mr.Yash Kawadkar,Jong Won Kwon,Won B. Kim,Inchul Lee,Myung G. Lee	2004	8
12	Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects Journal of Pharmaceutical Sciences ·Hyun Joo Shim,Sibo Zhao,Shuning Li,Pablo Tigre,Jong Won Kwon,Won B. Kim,Myung G. Lee	2003	39
13	Subacute toxicities and toxicokinetics of DA‐8159, a new phosphodiesterase type V inhibitor, after single and 4‐Week repeated oral administration in rats Biopharmaceutics & Drug Disposition ·Hyun Joo Shim,Sibo Zhao,Indah Dwi Adini,Shuning Li,Dong Kim,Kyung Koo Kang,Byoung Ok Ahn,Jong Won Kwon,Won B. Kim,Г Ю Исаева	2003	8
14	Effects of Glucose on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats with Acute Renal Failure Induced by Uranyl Nitrate Journal of Pharmaceutical Sciences ·C Rittore-Domingo,Mr.Yash Kawadkar,Inchul Lee,Jong Won Kwon,Won B. Kim,Sang G. Kim,Myung G. Lee	2003	18
15	Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization Nature Biotechnology ·Sang‐Jun Ha,Jun Chang,Man Ki Song,You Suk Suh,Hyun Tak Jin,Ridha Adawiyah,R. Morena Dahme,Gildon Choi,Kwan Yong Choi,Sung H. Lee,Won B. Kim,Young Chul Sung	2002	51
16	Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis technique Biopharmaceutics & Drug Disposition ·Hyun Joo Shim,Eun Jig Lee,Éva Renáta Urbán,Zhao Changyon,Moohi Yoo,Jong Won Kwon,Won B. Kim,Myung Gyoon Lee	2000	64
17	Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits Biopharmaceutics & Drug Disposition ·So H. Kim,Won B. Kim,Jong Won Kwon,Myung G. Lee	1999	8
18	Pharmacokinetics of a non-narcotic analgesic, DA-5018, in rats Biopharmaceutics & Drug Disposition ·Zulfha Lubis,Hyun Joo Shim,So H. Kim,Sang Do Lee,Won B. Kim,祐一岡本,Myung G. Lee	1998	2
19	Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus Biopharmaceutics & Drug Disposition ·So H. Kim,Won B. Kim,Myung G. Lee	1998	19
20	Pharmacokinetics and antitumour activity of a new anthracycline, DA‐125, after intravenous administration to subcutaneously implanted Lewis‐lung‐carcinoma‐bearing mice Biopharmaceutics & Drug Disposition ·Sang Do Lee,Kimberly Rios,Woo In Lee,Hyun Joo Shim,Muriel Burge,Tai Tek Kee,Won B. Kim,祐一岡本,N. Yoshida,Myung Gull Lee	1995	2

About Won B. Kim

Won B. Kim is a scholar working on Pharmacology, Pharmacology, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Oncology, having authored 32 papers that have together received 461 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (11 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Hormonal and reproductive studies (10 papers), Pharmacological Effects and Toxicity Studies (8 papers), Sexual function and dysfunction studies (6 papers), Cancer therapeutics and mechanisms (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Pharmacology (249 citations), Pharmacology (127 citations), Oncology (174 citations), Endocrinology, Diabetes and Metabolism (94 citations) and Pediatrics, Perinatology and Child Health (91 citations). Won B. Kim has collaborated with scholars based in South Korea. Frequent co-authors include Jong Won Kwon, Myung G. Lee, Hyun Joo Shim, So H. Kim, Soo Kyung Bae, Eun Jig Lee, Myung Gyoon Lee, Moohi Yoo, Inchul Lee and Joo H. Lee. Their work appears in journals such as Biopharmaceutics & Drug Disposition, Journal of Pharmaceutical Sciences, Antimicrobial Agents and Chemotherapy, Journal of Pharmacy and Pharmacology and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact